Entering text into the input field will update the search result below

Akebia shares slide following disappointing Q4 results

Feb. 25, 2021 9:16 AM ETAkebia Therapeutics, Inc. (AKBA) StockAKBABy: Jonathan Block, SA News Editor2 Comments
  • Akebia Therapeutics (NASDAQ:AKBA) posted Q4 2020 results that beat analyst expectations on revenue but missed on EPS.
  • Total revenue in the quarter was $56.7M compared to $69.6M in the prior-year period, an 18.5% decline.
  • The company's net loss year over year

Recommended For You

About AKBA Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
AKBA--
Akebia Therapeutics, Inc.